Share-based Payment Arrangement, Expense in USD of Verona Pharma plc from 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Verona Pharma plc quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2019 to Q2 2025.
  • Verona Pharma plc Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2025 was $34.8M, a 123% increase year-over-year.
  • Verona Pharma plc Share-based Payment Arrangement, Expense for the twelve months ending 30 Jun 2025 was $93.7M, a 218% increase year-over-year.
  • Verona Pharma plc annual Share-based Payment Arrangement, Expense for 2024 was $41.2M, a 117% increase from 2023.
  • Verona Pharma plc annual Share-based Payment Arrangement, Expense for 2023 was $19M, a 34.6% increase from 2022.
  • Verona Pharma plc annual Share-based Payment Arrangement, Expense for 2022 was $14.1M, unchanged from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Verona Pharma plc Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $93.7M $34.8M +$19.2M +123% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $74.5M $37.5M +$33.2M +780% 01 Jan 2025 31 Mar 2025 10-Q 29 Apr 2025
Q4 2024 $41.2M $13.7M +$9.17M +201% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025
Q3 2024 $32.1M $7.65M +$2.58M +50.7% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2024
Q2 2024 $29.5M $15.6M +$10.5M +207% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 $19M $4.26M -$32K -0.75% 01 Jan 2024 31 Mar 2024 10-Q 29 Apr 2025
Q4 2023 $19M $4.57M +$65K +1.44% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 $18.9M $5.08M +$2.26M +80.4% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024
Q2 2023 $16.7M $5.07M +$2.02M +66.2% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $14.7M $4.29M +$542K +14.5% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q4 2022 $14.1M $4.5M +$11.6M 01 Oct 2022 31 Dec 2022 10-K 29 Feb 2024
Q3 2022 $2.5M $2.82M -$2.12M -43% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023
Q2 2022 $4.62M $3.05M -$4.4M -59% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 $9.02M $3.75M -$5.1M -57.7% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 $14.1M -$7.12M -$20M -155% 01 Oct 2021 31 Dec 2021 10-K 27 Feb 2025
Q3 2021 $34.1M $4.94M -$1.55M -23.9% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $35.7M $7.45M +$6.5M +684% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $29.2M $8.85M +$6.98M +374% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022
Q4 2020 $22.2M $12.9M 01 Oct 2020 31 Dec 2020 10-K 03 Mar 2022
Q3 2020 $6.49M 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 $950K 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 $1.87M 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021

Verona Pharma plc Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $41.2M +$22.2M +117% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025
2023 $19M +$4.89M +34.6% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025
2022 $14.1M $0 0% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024
2021 $14.1M -$8.06M -36.3% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2025
2020 $22.2M +$19.1M +611% 01 Jan 2020 31 Dec 2020 10-K 03 Mar 2022
2019 $3.12M 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.